The breast cancer risk assessment test that detected Olivia Munn's aggressive Luminal B cancer has now identified breast ...

AbbVie has placed a high price on that potential, coughing up $700 million for a phase 1 candidate and offering up to $1.225 ...

After Olivia Munn was diagnosed with breast cancer in 2023, she urged her mom and sister to take a risk assessment test.

Princess Kate's charm and presence have become a cornerstone of the Royal Family’s popularity. From recent dazzling ...

In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...

While sites have not been finalized, the clinical trial will likely take place in Houston, the company's chief science ...